NASDAQ · Biotechnology

SNDX (SNDX) Stock

$19.77 -3.63% NASDAQ: SNDX Healthcare

Valuation

MetricValue
Price$19.77
Market Cap$1.75B
P/E Ratio-5.88
P/B Ratio26.39
P/S Ratio7.90
EPS (TTM)$-3.29
52-Week High$25.59
52-Week Low$8.59
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-438.46%
ROA-53.77%
ROCE-420.00%
Gross Margin-158.72%
Operating Margin-158.72%
Net Margin-1.12%
Debt/Equity8.30
Current Ratio4.40

Annual Financials (USD)

Metric20212022202320242025
Revenue$140.0M$0$0$24.0M$172.0M
Operating Profit$26.0M$-152.0M$-230.0M$-340.0M$-273.0M
Net Profit$25.0M$-149.0M$-209.0M$-319.0M$-285.0M
EPS$0.48$-2.46$-2.98$-3.73$-3.29
Op Margin18.8%——-1434.4%-158.4%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$450.0M$497.0M$613.0M$725.0M$530.0M
Total Liabilities$41.0M$30.0M$59.0M$437.0M$465.0M
Cash$222.0M$74.0M$295.0M$154.0M$135.0M
Borrowings$21.0M$1.0M$2.0M$346.0M$346.0M

Latest News

Syndax Pharmaceuticals (SNDX) Is Up 8.20% in One Week: What You Should Know Zacks · Jul 17, 2026 Syndax Pharmaceuticals Maps Growth Beyond Revuforj With Lung Cancer, Myelofibrosis Push MarketBeat · Jul 14, 2026 Wall Street Analysts Think Syndax (SNDX) Could Surge 70.38%: Read This Before Placing a Bet Zacks · Jul 14, 2026 Syndax to Highlight Late-Stage Programs and Unveil New Pipeline Assets at R&D Event GlobeNewswire · Jul 14, 2026 Syndax Pharmaceuticals Insider Sold Shares Worth $784,776, According to a Recent SEC Filing MT Newswires · Jul 9, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$29.0M$-134.0M$-161.0M$-275.0M$-323.0M
Investing Cash Flow$-41.0M$-186.0M$118.0M$-220.0M$290.0M
Financing Cash Flow$32.0M$12.0M$6.0M$344.0M$0
Net Cash Flow$107.0M$-148.0M$221.0M$-141.0M$-19.0M
Free Cash Flow$29.0M$-134.0M$-161.0M$-275.0M$-323.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-16.23%
Quick Ratio5.06
Interest Coverage-8.03
Return 1Y113.87%
Return 3Y3.72%
Return 5Y54.63%

Ownership

Insiders Held1.70%
Institutions Held117.25%
Institutions Float Held119.28%
Institutional HolderSharesReport Date
Blackrock Inc.8,254,4262026-03-31
Kynam Capital Management, LP8,050,9592026-03-31
Goldman Sachs Group Inc4,996,7872026-03-31
State Street Corporation4,430,0762026-03-31
Bank of America Corporation4,249,8362026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AMLX $22.82 -5.66% -8.69 $2.54B 0.00%
ATAI $7.25 +0.97% -8.44 $2.68B 0.00%
CVACCureVac N.V. $4.66 +0.00% 5.69 $1.05B 0.00%
IMTX $8.24 -4.52% -4.98 $1.10B 0.00%
INBXInhibrx Biosciences Inc. $81.54 -0.01% -9.72 $1.20B 0.00%

About SNDX

SNDX stock trades at $19.77 with a market capitalization of $1.75B. The stock is valued at a price-to-earnings (P/E) ratio of -5.88, price-to-book of 26.39, price-to-sales of 7.90. Over the past 52 weeks the stock has ranged between $8.59 and $25.59, and currently trades 22.7% below its 52-week high.

On profitability, SNDX generates a return on equity (ROE) of -438.46%, return on capital employed of -420.00%, an operating margin of -158.72%, a net profit margin of -1.12%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides